Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome.

Austin GL, Dalton CB, Hu Y, Morris CB, Hankins J, Weinland SR, Westman EC, Yancy WS Jr, Drossman DA.

Clin Gastroenterol Hepatol. 2009 Jun;7(6):706-708.e1. doi: 10.1016/j.cgh.2009.02.023.

2.

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.

Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG.

Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046.

PMID:
24076059
3.

Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.

Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS.

Gastroenterology. 2013 Aug;145(2):329-38.e1. doi: 10.1053/j.gastro.2013.04.006.

4.

The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.

J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1.

PMID:
22157240
5.

Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.

Basseri RJ, Kunkel D, Low K, Conklin JL, Pimentel M.

J Clin Gastroenterol. 2011 Oct;45(9):790-3. doi: 10.1097/MCG.0b013e3182053cea.

PMID:
21301356
6.

Efficacy of a Gluten-Free Diet in Subjects With Irritable Bowel Syndrome-Diarrhea Unaware of Their HLA-DQ2/8 Genotype.

Aziz I, Trott N, Briggs R, North JR, Hadjivassiliou M, Sanders DS.

Clin Gastroenterol Hepatol. 2016 May;14(5):696-703.e1. doi: 10.1016/j.cgh.2015.12.031.

PMID:
26748221
7.

Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients.

Andrae DA, Patrick DL, Drossman DA, Covington PS.

Health Qual Life Outcomes. 2013 Dec 13;11:208. doi: 10.1186/1477-7525-11-208.

8.

Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.

Bensoussan A, Kellow JE, Bourchier SJ, Fahey P, Shim L, Malcolm A, Boyce P.

Clin Gastroenterol Hepatol. 2015 Nov;13(11):1946-54.e1. doi: 10.1016/j.cgh.2015.06.022.

PMID:
26133902
9.

Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study.

Majeed M, Nagabhushanam K, Natarajan S, Sivakumar A, Ali F, Pande A, Majeed S, Karri SK.

Nutr J. 2016 Feb 27;15:21. doi: 10.1186/s12937-016-0140-6.

10.

Evaluation of crofelemer in the treatment of diarrhea-predominant irritable bowel syndrome patients.

Mangel AW, Chaturvedi P.

Digestion. 2008;78(4):180-6. doi: 10.1159/000185719.

PMID:
19092244
11.

Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency.

Leeds JS, Hopper AD, Sidhu R, Simmonette A, Azadbakht N, Hoggard N, Morley S, Sanders DS.

Clin Gastroenterol Hepatol. 2010 May;8(5):433-8. doi: 10.1016/j.cgh.2009.09.032.

PMID:
19835990
12.

Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii.

Bafutto M, Almeida JR, Leite NV, Costa MB, Oliveira EC, Resende-Filho J.

Arq Gastroenterol. 2013 Oct-Dec;50(4):304-9. doi: 10.1590/S0004-28032013000400012.

13.
14.

Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women.

Fukudo S, Kinoshita Y, Okumura T, Ida M, Akiho H, Nakashima Y, Nishida A, Haruma K.

Gastroenterology. 2016 Feb;150(2):358-66.e8. doi: 10.1053/j.gastro.2015.10.047.

15.

Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome.

Zhao JM, Wu LY, Liu HR, Hu HY, Wang JY, Huang RJ, Shi Y, Tao SP, Gao Q, Zhou CL, Qi L, Ma XP, Wu HG.

World J Gastroenterol. 2014 Oct 7;20(37):13563-72. doi: 10.3748/wjg.v20.i37.13563.

16.

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.

Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.

Gastroenterol Clin Biol. 2008 Feb;32(2):147-52. doi: 10.1016/j.gcb.2007.06.001.

17.

Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.

Choi CH, Kwon JG, Kim SK, Myung SJ, Park KS, Sohn CI, Rhee PL, Lee KJ, Lee OY, Jung HK, Jee SR, Jeen YT, Choi MG, Choi SC, Huh KC, Park H.

Neurogastroenterol Motil. 2015 May;27(5):705-16. doi: 10.1111/nmo.12544. Erratum in: Neurogastroenterol Motil. 2015 Nov;27(11):1684-5. Dosage error in article text.

18.

A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.

Chen C, Tao C, Liu Z, Lu M, Pan Q, Zheng L, Li Q, Song Z, Fichna J.

Phytother Res. 2015 Nov;29(11):1822-7. doi: 10.1002/ptr.5475.

PMID:
26400188
19.

Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern.

Heitkemper M, Cain KC, Shulman R, Burr R, Poppe A, Jarrett M.

Dig Dis Sci. 2011 Jul;56(7):2050-8. doi: 10.1007/s10620-011-1567-4.

20.

Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.

Lee KJ, Kim NY, Kwon JK, Huh KC, Lee OY, Lee JS, Choi SC, Sohn CI, Myung SJ, Park HJ, Choi MK, Bak YT, Rhee PL.

Neurogastroenterol Motil. 2011 Dec;23(12):1098-104. doi: 10.1111/j.1365-2982.2011.01771.x.

Items per page

Supplemental Content

Support Center